[
  {
    "ts": "2026-01-05T13:00:00+00:00",
    "headline": "Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America",
    "summary": "Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the more than 100 million Americans living with obesity.2 Wegovy® pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep i",
    "url": "https://finance.yahoo.com/news/novo-nordisks-wegovy-pill-first-130000047.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "38e27820-b910-3f1b-b5cf-88a2691e2147",
      "content": {
        "id": "38e27820-b910-3f1b-b5cf-88a2691e2147",
        "contentType": "STORY",
        "title": "Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America",
        "description": "",
        "summary": "Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the more than 100 million Americans living with obesity.2 Wegovy® pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep i",
        "pubDate": "2026-01-05T13:00:00Z",
        "displayTime": "2026-01-05T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b33acdc147ba24e772b0088bfe8f2846",
          "originalWidth": 400,
          "originalHeight": 290,
          "caption": "Image of 1.5mg starter dose of Wegovy® pill",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IzCMTp8XPN_b.l66dYe66A--~B/aD0yOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b33acdc147ba24e772b0088bfe8f2846.cf.webp",
              "width": 400,
              "height": 290,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oZ1HX6ENL.39DAnhWQuRkg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b33acdc147ba24e772b0088bfe8f2846.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisks-wegovy-pill-first-130000047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisks-wegovy-pill-first-130000047.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COST"
            },
            {
              "symbol": "LFMD"
            },
            {
              "symbol": "WW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]